Drug Information

Drug General Information
Drug ID
D03WMK
Former ID
DPR000008
Drug Name
AC-162352
Indication Obesity [ICD9: 278; ICD10:E66] Discontinued in Phase 1 [536122]
Company
Amylin
CAS Number
CAS 123583-37-9
Target and Pathway
Target(s) Neuropeptide Y receptor type 2 Target Info Agonist [536122]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 536122Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.
Ref 536122Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.